User:Mr. Ibrahem/Oteseconazole

Oteseconazole, sold under the brand name Vivjoa, is a medication used to decrease the frequency of recurrent vaginal yeast infections. It is taken by mouth. It may be used with fluconazole.

Commons side effects include headache and nausea. Use within two years of pregnancy may harm the baby and thus it should not be used in women who could become pregnant. Use is not recommended in those with significant kidney or liver problems. It is a 14α-demethylase (CYP51) inhibitor.

Oteseconazole was approved for medical use in the United States in 2022. It is not approved in Europe or the United Kingdom as of 2022. In the United States a course of treatment costs about 2,900 USD as of 2022.